Recent News

• 06.01.2026 - Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.29.2026 - Pulmonx Reports First Quarter 2026 Financial Results
• 04.28.2026 - Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference
• 04.15.2026 - Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
• 03.19.2026 - Phillip
• 03.04.2026 - Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
• 03.04.2026 - Pulmonx Announces Closing of up to $60 Million Credit Facility

Recent Filings

• 05.19.2026 - SD Specialized disclosure report
• 05.04.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2026 - EX-99.1 EX-99.1
• 04.29.2026 - 8-K Current report
• 04.22.2026 - ARS Annual Report to Security Holders
• 04.22.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.22.2026 - DEF 14A Other definitive proxy statements
• 03.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.10.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 03.10.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]